VERA Dividend History & Analysis | N/A Yield

VERA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

Yield 12m -

Payout Ratio -

Growth Rate CAGR 5y -

Consistency Lifetime 9.7%

Yield on Cost 5y -

Payout FCF -

Streak Years -

Dividend Rating 2.43%

Dividends Cash Amount per Share Yearly

Dividend Growth Year over Year

5 Years Chart with Price and Dividend Yield

■ Yield (right) | ■ Price (left) | ┅ Avg Yield

Total Return 12m: 17%

Total Return 5y: 278.3%

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group

Symbol	Market Cap USD	Dividend Yield TTM	Yield on Cost 5y
ABBV	387,093 M	3.34%	7.54%
AMGN	198,244 M	3.21%	5.93%
GILD	176,133 M	2.79%	5.63%
HLN	46,623 M	1.76%	2.46%
BIM	13,627 M	0.74%	0.75%

Top 5 Dividend Growth Rates of Peer-Group

Symbol	Market Cap USD	Growth Rate	Consistency
BTX	1,425 M	134%	95.6%
HLN	46,623 M	30.1%	100%
AMGN	198,244 M	7.84%	100%
BIM	13,627 M	9.76%	96.0%
ABBV	387,093 M	5.98%	100%

Quality Dividend Peers in Biotechnology

AMGN

Amgen
3.21% Yield

GILD

Gilead Sciences
2.79% Yield

VERA Dividend History: Last 12 Payments (USD) as of February 2026

Ex-Dividend Date	Dividend per Share	Dividend Growth Rate QoQ	Payout Yield
1996-01-10	0.02	0%	N/A
1995-06-30	0.02	0%	N/A
1995-01-17	0.02	0%	N/A
1994-06-13	0.02	0%	N/A
1994-01-04	0.02	0%	N/A
1993-06-10	0.02	0%	N/A
1992-12-08	0.02	0%	N/A
1992-06-04	0.02	0%	N/A
1991-12-04	0.02	0%	N/A
1991-05-30	0.02	0%	N/A
1990-12-11	0.02	0%	N/A
1990-05-25	0.02	0%	N/A

VERA Dividend FAQ

Vera Therapeutics, Inc. (NASDAQ: VERA) is a clinical-stage biotechnology firm developing immunology-focused therapies. Its lead candidate, atacicept-a fully humanized TACI-Fc fusion protein that simultaneously blocks BAFF and APRIL-is being tested as a sub-cutaneous, at-home treatment for immunoglobulin A nephropathy (IgAN). The pipeline also includes MAU868, a monoclonal antibody that completed a Phase 2 trial for BK virus viremia, and VT-109, a dual BAFF/APRIL inhibitor targeting B-cell-mediated autoimmune disorders. The company, originally incorporated in 2016 as Trucode Gene Repair, rebranded to Vera Therapeutics in April 2020 and is headquartered in Brisbane, California.

What is the Dividend Yield of VERA?

As of February 2026, VERA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 43.50.

Does VERA pay a dividend?

As of February 2026 VERA does not pay a dividend.

How often does VERA pay dividends?

Over the last 12 months, VERA has issued 0 dividend payments. The last dividend payment was made on 1996-01-10.

VERA dividend forecast

Based on historical data, the forecasted dividends per share for VERA for the next 4 payments are between 0.02 (+0.0%) and 0.02 (+0.0%).
This suggests the dividend will remain relatively stable.

Will VERA pay dividends in 2026?

The latest dividend paid per share was 0.02 USD with an Ex-Dividend Date of 1996-01-10. The next Ex-Dividend date for Vera Therapeutics (VERA) is currently unknown.

What is the next Ex-Dividend Date for VERA?

The next Ex-Dividend date for Vera Therapeutics (VERA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of VERA?

VERA's average dividend growth rate over the past 5 years is 0.00% per year.

What is the Yield on Cost of VERA?

VERA's 5-Year Yield on Cost is -%. If you bought VERA's shares at 11.50 USD five years ago, your current annual dividend income (- USD per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of VERA?

VERA Payout Consistency is 9.7%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: Vera Therapeutics has a poor track record of dividend payments over its lifetime.

Does VERA have a good Dividend Yield?

VERA`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of VERA?

The Dividend Payout Ratio of VERA is unknown.

What is the Dividend Rating of VERA?

VERA`s Overall Dividend Rating is 2.43%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

VERA Outstanding Shares Analysis

What is the Trend in VERA's Outstanding Shares?

Vera Therapeutics's outstanding shares have increased by approximately 42.72% annually over the past 3 years (Trend Reliability: 100.0%).

Significant dilution: Heavy share issuance is diluting existing shareholders. Even if total dividends paid increase, your dividend per share may stagnate or decline.

Has VERA ever had a Stock Split?

No stock splits on record. The share count changes shown above reflect buybacks, new issuance, or employee compensation rather than structural splits.

Year	Number of Shares	Annual Growth Rate
2021	13,000,000
2022	27,000,000	+107.69%
2023	43,000,000	+59.26%
2024	55,000,000	+27.91%

Key Metric Definitions

Dividend Yield: Annual dividend per share divided by current share price.
Payout Ratio: Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF: Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR): Compound annual growth rate of dividends over the last 5 years.
Consistency: Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost: Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak: Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating: Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-02-03 04:22